In an announcement from Xinjiang Bai Hua Cun Pharma Tech, the company's controlling shareholder, Hualing Gongmao, plans to transfer 79.5251 million shares of the company's unlimited circulating shares held by Mi Zaiqi, Mi Enhua, and Yang Xiaoling, accounting for 20.71% of the total share capital. The three common controlling shareholders and their concerted actors collectively hold 94.5251 million shares of the company, accounting for 24.62% of the total share capital.